Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats

This study aimed to exploit the potential therapeutic value of palmatine in treatment of cardiac hypertrophy and the underlying molecular mechanism. Rat hypertrophy model was established by intraperitoneal isoproterenol (ISO) injection. The hypertrophy was evaluated with cardiac hypertrophic paramet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Yonggang, Peng, Wanzhong, Liu, Yongxing, Xu, Zesheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806808/
https://www.ncbi.nlm.nih.gov/pubmed/29164959
http://dx.doi.org/10.1177/0394632017742225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806808/
https://www.ncbi.nlm.nih.gov/pubmed/29164959
http://dx.doi.org/10.1177/0394632017742225

Ejemplares similares